These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8658670

  • 1. Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression.
    Tanabe K, Koga S, Takahashi K, Sonda K, Tokumoto T, Babazono T, Yagisawa T, Toma H, Kawai T, Fuchinoue S, Teraoka S, Ota K.
    Transplant Proc; 1996 Jun; 28(3):1304-5. PubMed ID: 8658670
    [No Abstract] [Full Text] [Related]

  • 2. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K, Webber SA, Kurland G, Boyle GJ, Miller SA, Cipriani L, Griffith BP, Fricker FJ.
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [Abstract] [Full Text] [Related]

  • 3. Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506).
    Wilczek HE, Brattström C, Reinholt FP, Tydén G, Ericzon BG.
    Transplant Proc; 1996 Dec; 28(6):3177. PubMed ID: 8962232
    [No Abstract] [Full Text] [Related]

  • 4. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
    Vincenti F, Rostaing L, DIRECT (Diabetes Incidence after REnal Transplantation: Neoral C2 monitoring versus Tacrolimus) investigators.
    Contemp Clin Trials; 2005 Feb; 26(1):17-24. PubMed ID: 15837449
    [Abstract] [Full Text] [Related]

  • 5. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
    Hoitsma AJ, Hilbrands LB.
    Clin Transplant; 2006 Feb; 20(5):659-64. PubMed ID: 16968494
    [Abstract] [Full Text] [Related]

  • 6. Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study.
    Porrini E, Moreno JM, Osuna A, Benitez R, Lampreabe I, Diaz JM, Silva I, Domínguez R, Gonzalez-Cotorruelo J, Bayes B, Lauzurica R, Ibernon M, Moreso F, Delgado P, Torres A.
    Transplantation; 2008 Apr 27; 85(8):1133-8. PubMed ID: 18431233
    [Abstract] [Full Text] [Related]

  • 7. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
    Rodrigo E, de Cos MA, Fernández-Fresnedo G, Sánchez B, Ruiz JC, Piñera C, Palomar R, Cotorruelo JG, Gómez-Alamillo C, de Castro SS, de Francisco AL, Arias M.
    Transplant Proc; 2005 Nov 27; 37(9):3819-20. PubMed ID: 16386549
    [Abstract] [Full Text] [Related]

  • 8. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
    Chadban S.
    Nephrol Dial Transplant; 2008 Jun 27; 23(6):1816-8. PubMed ID: 18326882
    [No Abstract] [Full Text] [Related]

  • 9. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
    Ramos-Cebrián M, Torregrosa JV, Gutiérrez-Dalmau A, Oppenheimer F, Campistol JM.
    Transplant Proc; 2007 Sep 27; 39(7):2251-3. PubMed ID: 17889154
    [Abstract] [Full Text] [Related]

  • 10. Incidence and risk factors of new-onset diabetes mellitus after renal transplantation.
    Chien YS, Chen YT, Chuang CH, Cheng YT, Chuang FR, Hsieh H.
    Transplant Proc; 2008 Sep 27; 40(7):2409-11. PubMed ID: 18790250
    [Abstract] [Full Text] [Related]

  • 11. Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A.
    Kanzler S, Lohse AW, Schirmacher P, Hermann E, Otto G, Meyer zum Büschenfelde KH.
    Z Gastroenterol; 1996 Feb 27; 34(2):128-31. PubMed ID: 8659188
    [Abstract] [Full Text] [Related]

  • 12. Two-year follow-up study of the efficacy and safety of FK 506 in kidney transplant patients. Japanese FK 506 Study Group.
    Transpl Int; 1994 Feb 27; 7 Suppl 1():S247-51. PubMed ID: 11271216
    [Abstract] [Full Text] [Related]

  • 13. Posttransplant diabetes mellitus: incidence and risk factors.
    Mazali FC, Lalli CA, Alves-Filho G, Mazzali M.
    Transplant Proc; 2008 Apr 27; 40(3):764-6. PubMed ID: 18455010
    [Abstract] [Full Text] [Related]

  • 14. Is hepatitis C a risk factor to posttransplant diabetes mellitus after renal transplantation in patients using tacrolimus?
    Finni PE, Souza ER, Rioja S, Ventura S, Starling P, Almeida JR, Ruzany F.
    Transplant Proc; 2004 May 27; 36(4):884-5. PubMed ID: 15194303
    [Abstract] [Full Text] [Related]

  • 15. Posttransplant diabetes mellitus in renal allograft recipients.
    Koselj M, Koselj KM, Kveder R.
    Transplant Proc; 1992 Dec 27; 24(6):2756-7. PubMed ID: 1465929
    [No Abstract] [Full Text] [Related]

  • 16. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience.
    Marin M, Renoult E, Bondor CI, Kessler M.
    Transplant Proc; 2005 May 27; 37(4):1851-6. PubMed ID: 15919484
    [Abstract] [Full Text] [Related]

  • 17. Risk factors of acute tacrolimus nephrotoxicity in renal allografts.
    Shimizu T, Tanabe K, Tokumoto T, Ishikawa N, Shimmura H, Oshima T, Toma H, Yamaguchi Y.
    Transplant Proc; 2000 Nov 27; 32(7):1914-6. PubMed ID: 11119998
    [No Abstract] [Full Text] [Related]

  • 18. [Sugar diabetes after renal transplantation in children].
    Robert JJ, Tete MJ, Crosnier H, Broyer M.
    Ann Pediatr (Paris); 1993 Feb 27; 40(2):112-8. PubMed ID: 8457131
    [Abstract] [Full Text] [Related]

  • 19. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T, Inagaki A, Uchida K, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Tominaga Y, Okajima Y, Ohta K, Suga H, Taguchi S, Kakiya S, Itatsu T, Kobayashi T, Nakao A.
    Transplantation; 2003 Nov 15; 76(9):1320-6. PubMed ID: 14627910
    [Abstract] [Full Text] [Related]

  • 20. High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American Diabetes Association criteria.
    Cho YM, Park KS, Jung HS, Jeon HJ, Ahn C, Ha J, Kim SJ, Rhee BD, Kim SY, Lee HK.
    Diabetes Care; 2003 Apr 15; 26(4):1123-8. PubMed ID: 12663584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.